Menu
Recruiting NCT07324863

Ultrasound Guided External Oblique and Rectus Abdominis Plane Block (EXORA) on Neuroendocrine Stress Response in Adults Undergoing Umbilical Hernia Surgery

No phase Interventional Ultrasound External Oblique Rectus Abdominis Plane Block Neuroendocrine Stress Response

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: General anesthesia, External oblique and rectus abdominis plane (EXORA) block.
Who it may be relevant to
Registry conditions: Ultrasound, External Oblique, Rectus Abdominis Plane Block, Neuroendocrine Stress Response. Basic parameters: 21 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Ultrasound Guided External Oblique and Rectus Abdominis Plane Block (EXORA) on Neuroendocrine Stress Response in Adults Undergoing Umbilical Hernia Surgery: A Prospective Randomized Controlled Trial

Overview

This study aims to evaluate the efficacy of ultrasound-guided external oblique and rectus abdominis plane block on the neuroendocrine stress response and postoperative analgesia in adults undergoing umbilical hernia repair.

Detailed description

Umbilical hernias of the abdomen are defined as a non-inguinal, non-hiatal defect in the fascia of the abdominal wall. Surgical stress response refers to the physiologic response to surgery and the hormonal and metabolic changes that follow it.

Fascial plane blocks are gaining attention for perioperative analgesia due to their efficacy and safety profiles. The external oblique and rectus abdominis plane (EXORA) block is an emerging technique that provides a sensory block to the anterolateral abdominal wall, potentially filling gaps left by other commonly used blocks, such as the quadratus lumborum (QLB) or erector spinae plane (ESP) blocks.

Interventions

  • Other General anesthesia
    Patients will receive general anesthesia only.
  • Other External oblique and rectus abdominis plane (EXORA) block
    Patients will receive general anesthesia and an external oblique and rectus abdominis plane (EXORA) block with 0.25% bupivacaine.

Primary outcome measures

  • Neuroendocrine stress response [Time frame: 24 hours postoperatively]
Secondary outcome measures (5)
  • Serum cortisol level [Time frame: 24 hours postoperatively]
  • Time of first rescue analgesia [Time frame: 24 hours postoperatively]
  • Total intraoperative fentanyl consumption [Time frame: Intraoperatively]
  • Total morphine consumption [Time frame: 24 hours postoperatively]
  • Degree of pain [Time frame: 24 hours postoperatively]

Eligibility criteria

Inclusion criteria

  • Aged from 21 to 65 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) Physical status I and Ⅱ.
  • Schedule for elective umbilical hernia surgery under general anesthesia.

Exclusion criteria

  • ASA Ⅲ or Ⅳ.
  • Patients with metabolic abnormalities, e.g., diabetes mellitus.
  • Patients receiving corticosteroids.
  • History of allergies to local anesthetics.
  • Bleeding or coagulation disorders.
  • Anatomical abnormalities.
  • Psychiatric and neurological disorders.
  • Complicated hernial defect (obstructed).
  • Patient refusal.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Tanta University — Tanta

Identifiers

NCT: NCT07324863 · 36265MD474/10/25

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗